Indegene, a digital-first, life sciences commercialization company, announced the launch of a new center in Germany, expanding its client-focused consulting and management team in the region.
With this center, Indegene is further strengthening its presence in Europe to help life sciences companies fast-track digital transformation across the commercialization value chain. Indegene’s local expert teams will work closely with clients in Germany and across Europe to provide consulting services and healthcare solutions.
“Germany is a key market for life sciences companies in Europe. The scale and pace of innovation as well as the quality of talent we see here is incredible”, said Manish Gupta, Chairman and CEO, Indegene. “Our investment in Germany reiterates our continued commitment to the region."
The Misinformation Maze: Navigating Public Health in the Digital Age
March 11th 2025Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.